She represents boards of directors, audit committees and special committees on complex governance matters, including internal investigations, shareholder activism, leadership transitions, and related party transactions. She advises public companies on financial restatements and internal control issues and Sarbanes-Oxley implementation. She also regularly advises on SEC regulations and compliance issues faced by newly-listed public companies and companies preparing to go public. Ms. Goltser was recognized as a 2015 Capital Markets “Rising Star” by Law360 and is recommended for Corporate Governance by Legal 500 US.
Ms. Goltser advised on the corporate governance and securities regulation issues in connection with the following recent transactions:
- The Dow Chemical Company in its $130 billion all-stock merger of equals with E. I. du Pont de Nemours and Company
- York Capital Management, Valinor Management and Halcyon Capital Management, principal equity owners of NextDecade, LLC, in the $1 billion reverse merger of NextDecade with SPAC Harmony Merger Corp.
- Metaldyne Performance Group Inc. in its $3.3 billion sale to American Axle & Manufacturing Holdings, Inc.
- Nortek, Inc. in its $2.8 billion merger with Melrose Industries PLC and its acquisitions of 2GIG Technologies and the HVAC business of Thomas & Betts Corporation
- Engility Holdings, Inc. in its approximately $1.3 billion stock-for-stock merger with TASC, Inc.
- DIRECTV in the $67.1 billion transaction with AT&T
- MGM Resorts International in its formation of MGM Growth Properties LLC (MGP) and on the corporate aspects of MGP’s $1.05 billion initial public offering
- The Kroger Company in its $280 million acquisition of Vitacost.com, Inc.
- Board of Directors of Herbalife in defense of a position taken by Pershing Square and in connection with a financial restatement
- Health Management Associates, Inc. in its $7.6 billion sale to Community Health Systems, Inc., defense of a position taken by Glenview Capital Management and a financial restatement
- Fidelity National Financial, Inc. in its $2.9 billion acquisition of Lender Processing Services Inc. (n/k/a Black Knight, Inc.) and in the distribution of two tracking stocks
- Avista Healthcare Public Acquisition Corp., a SPAC sponsored by Avista Capital Holdings, in its proposed $924 million merger with Envigo International Holdings, Inc.
- Leucadia National Corporation in its $534 million acquisition of a minority interest in Jefferies Group, Inc.
Ms. Goltser has played a key role advising on the following recent IPOs:
- Ceridian HCM Holding, Inc. (a portfolio company of Thomas H. Lee Partners and Cannae Holdings, LLC) in its $531 million initial public offering and concurrent $100 million private placement of common shares at the IPO price
- NCS Multistage Holdings, Inc. (a portfolio company of Advent International) in its $186 million initial public offering
- Cotiviti Holdings, Inc. (f/k/a Connolly iHealth Technologies and a portfolio company of Advent International Corporation) in its $246 million initial public offering
- Ollie’s Bargain Outlet, Inc. (a portfolio company of CCMP Capital Advisors) in its $164 million initial public offering
- Black Knight Financial Services, Inc. (an indirect partially owned subsidiary of Fidelity National Financial, Inc.) in its $507 million initial public offering
- Metaldyne Performance Group Inc. (a portfolio company of American Securities) in its $170 million initial public offering
- Dave & Buster’s Entertainment, Inc. (a portfolio company of Oak Hill Capital Partners) in its $100 million initial public offering
- Papa Murphy's Holdings, Inc. (a portfolio company of Lee Equity Partners) in its $64 million initial public offering
- Vantiv, Inc. (a joint venture of Advent International and Fifth Third Bank) in its $575 million initial public offering
- AMC Entertainment Inc. (a subsidiary of China-based Dalian Wanda Group Co.) in its $379 million initial public offering
- Generac Holdings (a portfolio company of CCMP Capital Advisors) in its $270 million initial public offering
Ms. Goltser provides day-to-day counseling to numerous companies ranging from PE portfolio companies to the Fortune 500. She regularly advises on board-related issues, including director independence, board and committee structure, securities law compliance, board leadership structures, proxy access and other shareholder proposals, shareholder outreach and the impact of evolving institutional investor and proxy advisory firm policies.
Ms. Goltser is also an expert in Not-For-Profit governance. Ms. Goltser is involved with the Firm’s representation of numerous pro bono clients and is one of the leaders of the Firm’s representation of The Breast Cancer Research Foundation. Ms. Goltser was recognized by Legal Services NYC as one of the “Top 25 Pro Bono Advocates of 2015.” She is a member of the Firm’s Not‑for‑Profit practice and is a panelist at the Firm’s annual Symposium on Not-for-Profit Governance. She is the co-Chair of the Firm’s Summer Program Committee, serves on the Firm’s Hiring Committee and Diversity Committee, and is co-Chair of Women@Weil in New York.